The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
Open accessAbstract
This open, parallel-group study compares quinidine and sotalol treatment for maintenance of sinus rhythm after direct current conversion of patients with chronic atrial fibrillation. The patients from 15 centers in Sweden were randomized to sotalol (98 patients) or quinidine (85 patients) after 2 hours of sinus rhythm after direct current conversion. According to primary efficacy assessment, 52% of the patients in the sotalol group and 48% of the patients in the quinidine group remained in sinus rhythm during the following 6-month treatment period (NS). Furthermore, 34% of the patients treated with sotalol and 22% of the patients treated with quinidine relapsed into atrial fibrillation (NS). Heart rate after relapsing into atrial fibrillation was higher in the patients treated with quinidine (109 beats/min) than in the patients treated with sotalol (78 beats/min, p less than 0.001). Patients treated with sotalol were found to be less symptomatic at the time of relapse compared with relapsing patients in the quinidine group. In terms of safety, more patients were withdrawn from quinidine than from sotalol treatment (26% vs. 11%, p less than 0.05), and sotalol was generally better tolerated than quinidine. Twenty-eight percent of the patients treated with sotalol and 50% of the patients treated with quinidine reported side effects (p less than 0.01). The difference was primarily a result of early (within the first month of treatment) gastrointestinal and skin side effects in the group of patients treated with quinidine.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Chronic Atrial Fibrillation: Long‐term Results of Direct Current Conversion
LUNDSTRÖM, T., & RYDÉN, L. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15764.x · Cited by 225
Amiodarone for refractory atrial fibrillation
Gold, R. L., Haffajee, C. I., Charos, G., Sloan, K., Baker, S., & Alpert, J. S. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90964-1 · Cited by 218
Atrial Fibrillation: Natural History, Complications, And Management
Alpert, J. S., Petersen, P., & GODTFREDSEN, J. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.000353 · Cited by 156
Brodsky, M. A., Allen, B. J., Walker, C. J., Casey, T. P., Luckett, C. R., & Henry, W. L. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90307-9 · Cited by 154
Karlson, B. W., Torstensson, I., Abjörn, C., Jansson, S.-O., & PETERSON|, L. E. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062498 · Cited by 137
Campbell, T. J., Gavaghan, T. P., & Morgan, J. J. (1985) · Heart · doi:10.1136/hrt.54.1.86 · Cited by 112
Response of atrial fibrillation to therapy: Role of etiology and left atrial diameter
Ewy, G. A., Ulfers, L., Hager, W. D., Rosenfeld, A., Roeske, W. R., & Goldman, S. (1980) · Journal of Electrocardiology · doi:10.1016/s0022-0736(80)80042-2 · Cited by 93
Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation
Berns, E., Rinkenberger, R. L., Jeang, M. K., DOUGHERTY, A. H., Jenkins, M., & Naccarelli, G. V. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90915-5 · Cited by 92
Sotalol: A beta blocker with unique antiarrhythmic properties
Singh, B. N., & Nademanee, K. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90316-4 · Cited by 85
FACTORS INFLUENCING PERSISTENCE OF SINUS RHYTHM AFTER DC SHOCK TREATMENT OF ATRIAL FIBRILLATION
Waris, E., Kreus, K. ‐., & Salokannel, J. (1971) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1971.tb04358.x · Cited by 79
Lewis, R. V., IRVINE, N., & McDevitt, D. G. (1988) · European Heart Journal · doi:10.1093/eurheartj/9.7.777 · Cited by 71
Boissel, J., WOLF, E., GILLET, J., SOUBRANU, A., Cavallaro, A., Mazoyer, G., & DULAHYE, J. P. (1981) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061163 · Cited by 68
A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation
Lewis, R. V., Laing, E., Moreland, T. A., Service, E. G., & McDevitt, D. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062497 · Cited by 56
Drugs with a class III antiarrhythmic action
Bexton, R. S., & Camm, A. J. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90020-1 · Cited by 50
A comparison of verapamil and digoxin in the treatment of atrial fibrillation
LEWIS, R., LAKHANI, M., Moreland, T. A., & McDevitt, D. G. (1987) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062242 · Cited by 38
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 924
Metadata
- Authors
- Juul-Möller, S., Edvardsson, N., & Rehnqvist-Ahlberg, N.
- Venue
- Circulation
- Published
- 1990-12
- Volume
- 82
- Issue
- 6
- Pages
- 1932-1939
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2121682424
- Cited by
- 341
- References
- 16
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.